US Stock MarketDetailed Quotes

MURA Mural Oncology

Watchlist
  • 1.180
  • -0.170-12.59%
Close Mar 28 16:00 ET
  • 1.160
  • -0.020-1.70%
Post 20:01 ET
20.33MMarket Cap-0.16P/E (TTM)

Mural Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.54%138.26M
-38.72%35.85M
-26.37%34.1M
-27.47%34.28M
-22.93%34.03M
6.12%196.24M
23.54%58.51M
-6.06%46.31M
47.26M
44.16M
Selling and administrative expenses
-10.13%27.6M
-55.84%7.19M
9.30%6.51M
42.32%6.73M
91.27%7.17M
73.17%30.71M
227.43%16.27M
31.57%5.96M
--4.73M
--3.75M
-General and administrative expense
-10.13%27.6M
-55.84%7.19M
9.30%6.51M
42.32%6.73M
91.27%7.17M
73.17%30.71M
227.43%16.27M
31.57%5.96M
--4.73M
--3.75M
Research and development costs
-33.15%110.67M
-32.13%28.67M
-31.64%27.59M
-35.23%27.54M
-33.51%26.87M
-0.99%165.53M
-0.36%42.24M
-9.87%40.35M
--42.53M
--40.41M
Operating profit
29.54%-138.26M
38.72%-35.85M
26.37%-34.1M
27.47%-34.28M
22.93%-34.03M
-6.12%-196.24M
-23.54%-58.51M
6.06%-46.31M
-47.26M
-44.16M
Net non-operating interest income expense
Other net income (expense)
925.03%9.75M
1.58M
2.34M
2.71M
3.12M
951K
Other non- operating income (expenses)
925.03%9.75M
--1.58M
--2.34M
--2.71M
--3.12M
--951K
----
----
----
----
Income before tax
34.19%-128.51M
40.46%-34.27M
31.43%-31.76M
33.21%-31.56M
29.98%-30.92M
-5.60%-195.29M
-21.53%-57.56M
6.06%-46.31M
-47.26M
-44.16M
Income tax
0
0
0
0
0
148.98%12.16M
61.89%1.98M
270.32%4.97M
2.91M
2.31M
Net income
38.05%-128.51M
42.43%-34.27M
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
Net income continuous Operations
38.05%-128.51M
42.43%-34.27M
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
---50.16M
---46.47M
Minority interest income
Net income attributable to the parent company
38.05%-128.51M
42.43%-34.27M
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
38.05%-128.51M
42.43%-34.27M
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
Basic earnings per share
39.02%-7.58
43.65%-2.01
39.14%-1.87
38.12%-1.86
33.92%-1.84
-9.29%-12.43
-22.54%-3.5672
-1.25%-3.0728
-3.006
-2.7844
Diluted earnings per share
39.02%-7.58
43.65%-2.01
39.14%-1.87
38.12%-1.86
33.92%-1.84
-9.29%-12.43
-22.54%-3.5672
-1.25%-3.0728
-3.006
-2.7844
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.54%138.26M-38.72%35.85M-26.37%34.1M-27.47%34.28M-22.93%34.03M6.12%196.24M23.54%58.51M-6.06%46.31M47.26M44.16M
Selling and administrative expenses -10.13%27.6M-55.84%7.19M9.30%6.51M42.32%6.73M91.27%7.17M73.17%30.71M227.43%16.27M31.57%5.96M--4.73M--3.75M
-General and administrative expense -10.13%27.6M-55.84%7.19M9.30%6.51M42.32%6.73M91.27%7.17M73.17%30.71M227.43%16.27M31.57%5.96M--4.73M--3.75M
Research and development costs -33.15%110.67M-32.13%28.67M-31.64%27.59M-35.23%27.54M-33.51%26.87M-0.99%165.53M-0.36%42.24M-9.87%40.35M--42.53M--40.41M
Operating profit 29.54%-138.26M38.72%-35.85M26.37%-34.1M27.47%-34.28M22.93%-34.03M-6.12%-196.24M-23.54%-58.51M6.06%-46.31M-47.26M-44.16M
Net non-operating interest income expense
Other net income (expense) 925.03%9.75M1.58M2.34M2.71M3.12M951K
Other non- operating income (expenses) 925.03%9.75M--1.58M--2.34M--2.71M--3.12M--951K----------------
Income before tax 34.19%-128.51M40.46%-34.27M31.43%-31.76M33.21%-31.56M29.98%-30.92M-5.60%-195.29M-21.53%-57.56M6.06%-46.31M-47.26M-44.16M
Income tax 00000148.98%12.16M61.89%1.98M270.32%4.97M2.91M2.31M
Net income 38.05%-128.51M42.43%-34.27M38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M
Net income continuous Operations 38.05%-128.51M42.43%-34.27M38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M---50.16M---46.47M
Minority interest income
Net income attributable to the parent company 38.05%-128.51M42.43%-34.27M38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 38.05%-128.51M42.43%-34.27M38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M
Basic earnings per share 39.02%-7.5843.65%-2.0139.14%-1.8738.12%-1.8633.92%-1.84-9.29%-12.43-22.54%-3.5672-1.25%-3.0728-3.006-2.7844
Diluted earnings per share 39.02%-7.5843.65%-2.0139.14%-1.8738.12%-1.8633.92%-1.84-9.29%-12.43-22.54%-3.5672-1.25%-3.0728-3.006-2.7844
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.950
eBay
EBAY
67.160
Collegium Pharmaceutical
COLL
29.710
4
Dorian LPG
LPG
22.500
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.325
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.